Dr. Collins trained under Dr. Fred L. Shapiro, an innovator in kidney disease
care, and founder of the Regional Kidney Disease
Program (RKDP), the first program of its kind
for dialysis and transplant patients, with an
extensive demographic and clinical database in
place by 1973. Dr. Collins served as the RKDP
Medical Director, and assumed responsibility for
research operations in 1983.
Building on RKDP data systems and biostatistical
support, Dr. Collins and NAS created a comprehensive
end-stage renal disease (ESRD) database of demographic,
clinical, and provider information capable of
answering a variety of observational research
questions. With a research agenda expanded to
include chronic kidney disease, cardiovascular
disease, diabetes, anemia, dementia, and other
conditions, CDRG investigators use large public
and private pharmaceutical, claims, and clinical
databases to analyze healthcare practices and
systems and evaluate their impact on morbidity,
survival, quality of life, and healthcare costs.
CDRG expertise includes data management and analysis and clinical trial support using advanced computer systems. Our clinician-guided research support benefits pharmaceutical, biotechnical, and biochemical sponsors; health plans; universities; and government agencies concerned with improving patient care. We create project-specific data reports to interpret and summarize our findings.
We regularly publish
our research in peer-reviewed medical journals
and members of our group present
findings at national and international meetings.